Endocrine therapy in breast cancer
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York [u.a.]
Dekker
2002
|
| Schlagworte: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV014150413 | ||
| 003 | DE-604 | ||
| 005 | 20170727 | ||
| 007 | t| | ||
| 008 | 020214s2002 xx d||| |||| 00||| eng d | ||
| 020 | |a 0824707877 |9 0-8247-0787-7 | ||
| 035 | |a (OCoLC)48958485 | ||
| 035 | |a (DE-599)BVBBV014150413 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-12 | ||
| 050 | 0 | |a RC280.B8 | |
| 082 | 0 | |a 616.99/449061 |2 21 | |
| 084 | |a XH 8465 |0 (DE-625)152958:13144 |2 rvk | ||
| 245 | 1 | 0 | |a Endocrine therapy in breast cancer |c ed. by William R. Miller ... |
| 264 | 1 | |a New York [u.a.] |b Dekker |c 2002 | |
| 300 | |a XIV, 378 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Antineoplastic Agents, Hormonal |x therapeutic use |v Congresses | |
| 650 | 4 | |a Breast Neoplasms |x drug therapy |v Congresses | |
| 650 | 4 | |a Breast Neoplasms |x prevention & control |v Congresses | |
| 650 | 4 | |a Breast |x Cancer |x Endocrine aspects |v Congresses | |
| 650 | 4 | |a Chemotherapy, Adjuvant |x methods |v Congresses | |
| 650 | 4 | |a Selective estrogen receptor modulators |v Congresses | |
| 650 | 4 | |a Tamoxifen |v Congresses | |
| 650 | 0 | 7 | |a Aromatasehemmer |0 (DE-588)4192306-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Brustkrebs |0 (DE-588)4008528-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Antiöstrogene |0 (DE-588)4142728-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hormontherapie |0 (DE-588)4025870-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 655 | 7 | |a Tamoxiten |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
| 689 | 0 | 1 | |a Hormontherapie |0 (DE-588)4025870-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
| 689 | 1 | 1 | |a Aromatasehemmer |0 (DE-588)4192306-6 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
| 689 | 2 | 1 | |a Tamoxiten |A f |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
| 689 | 3 | 1 | |a Antiöstrogene |0 (DE-588)4142728-2 |D s |
| 689 | 3 | |5 DE-604 | |
| 700 | 1 | |a Miller, William R. |e Sonstige |4 oth | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-009698056 | |
Datensatz im Suchindex
| DE-BY-UBR_call_number | 91/XH 8465 M652 E5 |
|---|---|
| DE-BY-UBR_katkey | 3258889 |
| DE-BY-UBR_location | 91 |
| DE-BY-UBR_media_number | 069030966670 |
| _version_ | 1822696420791025664 |
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV014150413 |
| callnumber-first | R - Medicine |
| callnumber-label | RC280 |
| callnumber-raw | RC280.B8 |
| callnumber-search | RC280.B8 |
| callnumber-sort | RC 3280 B8 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XH 8465 |
| ctrlnum | (OCoLC)48958485 (DE-599)BVBBV014150413 |
| dewey-full | 616.99/449061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/449061 |
| dewey-search | 616.99/449061 |
| dewey-sort | 3616.99 6449061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02173nam a2200601 c 4500</leader><controlfield tag="001">BV014150413</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20170727 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">020214s2002 xx d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0824707877</subfield><subfield code="9">0-8247-0787-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)48958485</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV014150413</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC280.B8</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/449061</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 8465</subfield><subfield code="0">(DE-625)152958:13144</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Endocrine therapy in breast cancer</subfield><subfield code="c">ed. by William R. Miller ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Dekker</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIV, 378 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents, Hormonal</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast Neoplasms</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast Neoplasms</subfield><subfield code="x">prevention & control</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast</subfield><subfield code="x">Cancer</subfield><subfield code="x">Endocrine aspects</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemotherapy, Adjuvant</subfield><subfield code="x">methods</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Selective estrogen receptor modulators</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tamoxifen</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Aromatasehemmer</subfield><subfield code="0">(DE-588)4192306-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antiöstrogene</subfield><subfield code="0">(DE-588)4142728-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hormontherapie</subfield><subfield code="0">(DE-588)4025870-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Tamoxiten</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Hormontherapie</subfield><subfield code="0">(DE-588)4025870-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Aromatasehemmer</subfield><subfield code="0">(DE-588)4192306-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Tamoxiten</subfield><subfield code="A">f</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Antiöstrogene</subfield><subfield code="0">(DE-588)4142728-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Miller, William R.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009698056</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content Tamoxiten gnd |
| genre_facet | Aufsatzsammlung Konferenzschrift Tamoxiten |
| id | DE-604.BV014150413 |
| illustrated | Illustrated |
| indexdate | 2024-12-23T15:48:26Z |
| institution | BVB |
| isbn | 0824707877 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009698056 |
| oclc_num | 48958485 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-12 |
| owner_facet | DE-355 DE-BY-UBR DE-12 |
| physical | XIV, 378 S. graph. Darst. |
| publishDate | 2002 |
| publishDateSearch | 2002 |
| publishDateSort | 2002 |
| publisher | Dekker |
| record_format | marc |
| spellingShingle | Endocrine therapy in breast cancer Antineoplastic Agents, Hormonal therapeutic use Congresses Breast Neoplasms drug therapy Congresses Breast Neoplasms prevention & control Congresses Breast Cancer Endocrine aspects Congresses Chemotherapy, Adjuvant methods Congresses Selective estrogen receptor modulators Congresses Tamoxifen Congresses Aromatasehemmer (DE-588)4192306-6 gnd Brustkrebs (DE-588)4008528-4 gnd Antiöstrogene (DE-588)4142728-2 gnd Hormontherapie (DE-588)4025870-1 gnd |
| subject_GND | (DE-588)4192306-6 (DE-588)4008528-4 (DE-588)4142728-2 (DE-588)4025870-1 (DE-588)4143413-4 (DE-588)1071861417 |
| title | Endocrine therapy in breast cancer |
| title_auth | Endocrine therapy in breast cancer |
| title_exact_search | Endocrine therapy in breast cancer |
| title_full | Endocrine therapy in breast cancer ed. by William R. Miller ... |
| title_fullStr | Endocrine therapy in breast cancer ed. by William R. Miller ... |
| title_full_unstemmed | Endocrine therapy in breast cancer ed. by William R. Miller ... |
| title_short | Endocrine therapy in breast cancer |
| title_sort | endocrine therapy in breast cancer |
| topic | Antineoplastic Agents, Hormonal therapeutic use Congresses Breast Neoplasms drug therapy Congresses Breast Neoplasms prevention & control Congresses Breast Cancer Endocrine aspects Congresses Chemotherapy, Adjuvant methods Congresses Selective estrogen receptor modulators Congresses Tamoxifen Congresses Aromatasehemmer (DE-588)4192306-6 gnd Brustkrebs (DE-588)4008528-4 gnd Antiöstrogene (DE-588)4142728-2 gnd Hormontherapie (DE-588)4025870-1 gnd |
| topic_facet | Antineoplastic Agents, Hormonal therapeutic use Congresses Breast Neoplasms drug therapy Congresses Breast Neoplasms prevention & control Congresses Breast Cancer Endocrine aspects Congresses Chemotherapy, Adjuvant methods Congresses Selective estrogen receptor modulators Congresses Tamoxifen Congresses Aromatasehemmer Brustkrebs Antiöstrogene Hormontherapie Aufsatzsammlung Konferenzschrift Tamoxiten |
| work_keys_str_mv | AT millerwilliamr endocrinetherapyinbreastcancer |